Skip to main content
. 2022 Feb 10;16(4):261–275. doi: 10.1111/crj.13479

TABLE 1.

Quality scale used to assess the included studies

Item assessed Characteristic Weight
Total sample size 100–1000 0
1001‐10 000 1
>10 000 2
Number of COPD never‐smoker cases 20–100 0
101–300 1
>300 2
Covariate adjustment (number) 2 (age and sex) 0
>2 2

Study design

Cross‐sectional study 0
Case–control study 1
Cohort study 2

COPD diagnosis

Spirometry not registered or patient‐reported symptoms 0
Pre‐bronchodilator FEV1/FVC < 70% 1
Post‐bronchodilator FEV1/FVC < 70% 2
Total 10